Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BMO Capital Downgrades Horizon Therapeutics to Market Perform

BMO Capital analyst Gary Nachman downgrades Horizon Therapeutics (NASDAQ:HZNP) from Outperform to Market Perform.

December 13, 2022

1 minute read

BMO Capital analyst Gary Nachman downgrades Horizon Therapeutics (NASDAQ:HZNP) from Outperform to Market Perform.

HC Wainwright & Co. Maintains Buy on Codexis, Raises Price Target to $38

Today, 7:03 AM

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Codexis (NASDAQ:CDXS) with a Buy and raises the price target from $33 to $38.

Today, 7:03 AM

Piper Sandler analyst Adam Maeder maintains ShockWave Medical (NASDAQ:SWAV) with a Overweight and lowers the price target from $300 to $280.

Today, 7:03 AM

-Reuters

Today, 7:03 AM

RBC Capital analyst Mike Dahl maintains Vulcan Materials (NYSE:VMC) with a Sector Perform and raises the price target from $182 to $198.